Afatinib side effects and treatment methods

Afatinib as an EGFR inhibitor, is widely used in the treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC). Although the drug has a significant therapeutic effect on patients, it also comes with certain side effects. Understanding these side effects and taking appropriate management measures are critical to optimizing treatment effectiveness.

The most common side effects of afatinib are skin reactions, including rash and dryness. The rash usually appears on the face, neck, and back and may be accompanied by mild itching. Such side effects are caused by afatinib's inhibition of the EGFR receptor, which is not only expressed on tumor cells but also plays a role in skin cells. To relieve rashes, patients can use mild skin care products, avoid sun exposure, and use ointments as recommended by their doctor. For severe rash, dose reduction or temporary discontinuation may be considered.

Another common side effect is diarrhea, which usually occurs during the first few weeks of treatment. Diarrhea may be mild, but if left untreated, it can lead to dehydration or electrolyte imbalance. Patients should stay well hydrated, use anti-diarrhea medications such as loperamide (Imodium), and avoid high-fiber or greasy foods. If diarrhea symptoms are severe, you should communicate with your doctor in time to adjust the drug dosage.

In addition, afatinib may cause digestive system problems such as oral ulcers, loss of appetite, and nausea. Patients can reduce the occurrence of oral ulcers by maintaining good oral hygiene and avoiding spicy foods. For nausea and loss of appetite, you can consider using appropriate anti-nausea medications and adjusting your diet.

In rare cases, afatinib may cause serious side effects, such as liver function abnormalities and interstitial lung disease. Patients should undergo liver function and pulmonary function tests regularly, and if abnormalities are found, they should be dealt with promptly. Patients with hepatic impairment may require dose adjustments or alternative treatment options.

Reference materials:https://www.giotrif.com/